Georgetown University
Clinical trials sponsored by Georgetown University, explained in plain language.
-
New Triple-Drug attack shows promise for tough lung cancer
Disease control OngoingThis study tests whether adding tiragolumab to standard immunotherapy (atezolizumab) and anti-angiogenesis therapy (bevacizumab) can shrink tumors in people with advanced non-squamous non-small-cell lung cancer that has worsened after prior treatment. About 29 adults with specifi…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
New hope for tough lung cancer? drug trial targets relapsed cases
Disease control OngoingThis study tests a drug called MGC018 in people with a type of advanced lung cancer (small-cell) that has returned or not responded to treatment. The main goal is to see if the drug can shrink tumors in at least 25% of participants. Nine adults will receive the drug through an IV…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC